Investing
Cathie Wood's ARK Invest Buys Over 340,000 Shares of Signify Health
Published:
One of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge purchase on Tuesday. This fund bought over 340,000 shares of Signify Health Inc. (NYSE: SGFY), as the price of this ETF dropped around 0.6% on Tuesday. Note that this ETF is still up handily in the past year.
It was ARK Genomic Revolution ETF (NYSEARCA: ARKG) that bought 340,872 shares of Signify Health. At Tuesday’s closing price, this would have valued this purchase at $8.5 million. Even though this is a small fraction of the total holdings, every little bit counts. the fund is up 73% in the last year.
Check out all of ARK Invest’s buys for Tuesday:
Fund | Ticker | Company | Shares |
---|---|---|---|
ARKF | KSPILI | KASPI.KZ JSC | 8,915 |
ARKG | VEEV | VEEVA SYSTEMS INC | 46,386 |
ARKG | SGFY | SIGNIFY HEALTH INC | 340,872 |
ARKG | SEER | SEER INC | 145,050 |
ARKG | RPTX | REPARE THERAPEUTICS INC | 7,676 |
ARKG | MASS | 908 DEVICES INC | 229 |
ARKG | CMLF | CM LIFE SCIENCES INC | 4,000 |
ARKG | CMIIU | CM LIFE SCIENCES II INC | 1,800 |
ARKG | CDXS | CODEXIS INC | 10,000 |
ARKK | EXAS | EXACT SCIENCES CORP | 69,430 |
ARKQ | SPFR | JAWS SPITFIRE ACQUISITION CORP | 100,000 |
ARKQ | ISRG | INTUITIVE SURGICAL INC | 10,422 |
ARKQ | KTOS | KRATOS DEFENSE & SECURITY SOLUTIONS INC | 570 |
ARKQ | NIU | NIU TECHNOLOGIES | 6,361 |
ARKW | VUZI | VUZIX CORP | 271,517 |
ARKX | NFLX | NETFLIX INC | 3,182 |
ARKX | RTP | REINVENT TECHNOLOGY PARTNERS | 2,400 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.